AI can support risk of bias assessment by locating methodological evidence, drafting extraction entries, and preparing answers to signalling questions. The assessor makes the final judgments, using the appropriate tool and checking every supporting passage against the original study.
A fluent summary can still confuse missing reporting with flawed methods or apply the wrong criteria. Start by identifying the study design and the exact result you want to assess.
Match the Tool to the Study Design
The right tool depends on the research question and design. For observational studies, choose a tool based on whether the study examines an intervention or an exposure. For mixed-design reviews, use the appropriate tool for each design rather than forcing every study into one checklist.
These tools address different sources of bias.
Study or question | Tool | Main focus |
|---|---|---|
Randomized intervention trial | RoB 2 | Five domains affecting a particular result |
Non-randomized intervention study | ROBINS-I | Confounding, participant selection, intervention classification, missing data, and other biases |
Environmental, occupational, or other non-intervention exposure | ROBINS-E | Bias in estimated exposure effects |
Diagnostic test accuracy | QUADAS-2 | Patient selection, index test, reference standard, and flow and timing |
Systematic review, including reviews assessed in umbrella reviews | ROBIS | Bias in the review process itself |
Cohort or case-control study | Newcastle-Ottawa Scale | Selection, comparability, and outcome or exposure assessment |
QUADAS-2 assesses both risk of bias and applicability. ROBIS evaluates a systematic review, so it isn't a substitute for assessing its included studies.

Cochrane's ROBINS-I overview describes its use for non-randomized studies of interventions. ROBINS-I version 2 uses algorithms to suggest judgments from signalling answers. It also adds explicit questions about immortal time bias, which the 2016 version omitted.
Most approaches use domain-based evaluations or checklists rather than simple numerical scores. The Newcastle-Ottawa Scale is a star-based exception; don't translate its stars into another tool's domain categories.
Define the Result Before Applying RoB 2
Risk of bias assessment focuses on methodological flaws that create systematic errors capable of distorting a specific result. Although often grouped under "quality assessment" or "critical appraisal," it is narrower than judging a paper's overall usefulness.
Specify the outcome and effect
Record the intervention, comparator, outcome, time point, and analysis being assessed. For a randomized trial, also distinguish the effect of assignment to intervention from the effect of adhering to intervention.
One trial can have different risks for different outcomes. For example, awareness of treatment may affect self-reported pain more than an objectively recorded death.
Work through the five domains
Cochrane's guidance uses signalling questions across five domains:
Bias arising from the randomization process.
Bias due to deviations from intended interventions.
Bias due to missing outcome data.
Bias in measurement of the outcome.
Bias in selection of the reported result.
Each domain receives low risk, some concerns, or high risk. AI can organize evidence for these questions, but the tool's definitions govern the answers.
Use AI for Screening and Evidence Extraction
In an evidence synthesis, keep eligibility decisions separate from risk-of-bias appraisal. A study can meet your inclusion criteria and still have a high risk of bias.
Support screening without delegating exclusions
AI can identify likely study designs, locate companion reports, and flag uncertain eligibility. However, an abstract rarely contains enough detail for a defensible domain-level assessment.
Our guide to AI tools for systematic reviews separates screening, extraction, and appraisal tasks. Rayyan and Covidence support organized screening decisions, while ASReview LAB prioritizes records through active learning.
Test ranking against known eligible studies. Keep unclear records for human review, because a smaller queue has little value if eligible evidence disappears.
Extract passages before requesting judgments
Gather the full paper, supplements, protocol, registration, and analysis plan where available. In our AI Document Chat, begin with narrow questions tied to those documents.
A useful extraction prompt is:
Using only the supplied documents, extract evidence relevant to each signalling question. Include the document name, page or section, and supporting passage. Write "Not reported" when information is absent. Keep proposed answers separate from evidence, and don't assign a final judgment.

Inspect tables and footnotes yourself. Models can confuse background citations with the study's methods or mistake a subgroup result for the main analysis. Our source-grounded paper-reading workflow keeps those checks alongside document chat.
Turn Verified Evidence Into Domain Judgments
Treat an AI-generated answer as a proposal with an evidence trail. A source citation helps only when its passage supports the attached claim.
Answer signalling questions using the tool's rules
For every question, retain the source passage, your answer, and a short rationale. RoB 2 permits answers such as yes, probably yes, probably no, no, and no information, depending on the question.
Don't replace those options with an invented confidence score. Likewise, missing reporting doesn't automatically establish that a procedure was inadequate.
Check AI-extracted denominators, follow-up times, and missing-data statements against the paper. Then apply the tool's algorithm. If you override a suggested judgment, document why.
Derive the overall judgment without averaging
Cochrane Handbook Chapter 8 describes assessment of a specific randomized-trial result.
Under this tool, low risk overall requires low risk across all domains. Some concerns in at least one domain, with no high-risk domain, generally means some concerns overall.
A high-risk domain produces high risk overall. Multiple domains with some concerns can also justify high risk when they substantially reduce confidence in the result.
Never average domain ratings into a numerical "quality percentage." That can hide a serious problem behind several reassuring judgments.
Worked Example: Reviewing the RECOVERY Dexamethasone Trial
The RECOVERY Collaborative Group's Dexamethasone in Hospitalized Patients with Covid-19, published in the New England Journal of Medicine, provides a useful case. It was a randomized, open-label comparison with 28-day mortality as the primary outcome.
Extract the relevant facts
Select the 28-day mortality result for dexamethasone versus usual care and assess the effect of assignment.
Ask AI to locate allocation procedures, treatment awareness, mortality ascertainment, follow-up completeness, and the planned analysis. Then open each cited section.
The report describes web-based randomization with concealed allocation. It also states that patients and treating clinicians knew the assigned treatment. Keep those facts separate: open-label treatment doesn't establish failure of allocation concealment.
For mortality, inspect the paper's follow-up information rather than accepting an AI statement that "all participants completed follow-up."
Correct the interpretation before rating
An AI answer that assigns high measurement bias solely because the trial was open-label needs correction. Mortality is less susceptible to assessor interpretation than a subjective symptom score.
However, lack of blinding still requires attention under deviations from intended interventions. Examine whether trial-related deviations occurred and whether the analysis appropriately estimated the assignment effect.
Next, compare reported outcomes and analyses with the protocol and statistical analysis plan. Don't infer selective reporting from a mismatch without examining its explanation.
This produces supported answers for individual domains. It doesn't justify an overall rating until all five domains have been assessed.
Report the Assessment and Its Consequences
A traffic light table is useful, but readers also need the reasoning behind its colors.
Preserve an auditable record
Retain the tool and version, target result, supporting passages, signalling answers, domain judgments, and overall judgment. Also record the AI system, date, prompts, available settings, and reviewer corrections.
For team reviews, assess independently before reconciling disagreements. Shared AI suggestions can anchor both reviewers to the same error.
Before uploading sensitive or unpublished documents, apply institutional rules on access, retention, and permitted AI use.
Cochrane Handbook Chapter 7 addresses bias and conflicts of interest among included studies; Chapter 8 addresses randomized-trial assessment. Both are listed in Midwestern University's assessment resources.
Visualize findings and interpret the evidence
The robvis web app visualizes the assessment results described in this article. Cite the robvis methods publication when using its visualizations.
Keep concise domain rationales beside the figure or in an appendix.
In meta-analyses, use risk of bias to inform interpretation and prespecified sensitivity analyses. Compare conclusions with and without high-risk results rather than automatically excluding studies after seeing their findings.
GRADE structures the assessment and presentation of certainty across a body of evidence. Study-level risk of bias informs GRADE, but it isn't the entire certainty judgment.
Key Takeaways
Choose the appraisal tool by study design and define the exact result before extracting evidence.
Use AI to locate passages and prepare answers, while keeping suggestions separate from verified decisions.
Preserve domain rationales, reviewer corrections, and source locations so another researcher can reconstruct the assessment.
Frequently Asked Questions
Can AI replace a second assessor?
AI isn't an independent human assessor. It may repeat the first reviewer's assumptions or produce the same unsupported answer across repeated prompts.
Where your review requires independent duplicate assessment, retain that process. AI can help both reviewers find evidence, but it doesn't fulfill the second-reviewer role.
Does "not reported" mean high risk?
No. "Not reported" describes the available information, not an automatic judgment about the methods.
Use the tool's signalling-question guidance and inspect companion reports or protocols. Missing information may lead to concerns, but the consequence depends on the domain and question. Record uncertainty rather than inventing reassuring details.
Keep the Final Judgment Tied to Evidence
AI is useful when it makes methodological evidence easier to find and inspect. Its contribution ends with supported suggestions; accountability stays with the assessor.
Choose the right tool, define the result, and preserve the reasoning behind each judgment. A defensible assessment lets another researcher follow the path from the original paper to the final rating.